Rainer Landgraf

Q: What Schools Are Affiliated With Rainer Landgraf

Rainer Landgraf is affiliated with the following schools: University of Calgary, Wake Forest University

Rainer Landgraf's AcademicInfluence.com Rankings

Rainer Landgraf

Philosophy

#6293

World Rank

#9305

Historical Rank

Ontology

#53

World Rank

#63

Historical Rank

Logic

#3468

World Rank

#4630

Historical Rank

philosophy Degrees

Rainer Landgraf

Biology

#8531

World Rank

#11625

Historical Rank

Endocrinology

#94

World Rank

#105

Historical Rank

Neuroscience

#1182

World Rank

#1225

Historical Rank

Biochemistry

#1236

World Rank

#1355

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Rainer Landgraf's Degrees

PhD Neuroscience University of California, San Francisco
Doctorate Medicine University of California, San Francisco

Why Is Rainer Landgraf Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Rainer Landgraf's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication (2004) (960)
Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors (2012) (754)
Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice (2013) (442)
The hypothalamic–neurohypophysial system regulates the hypothalamic–pituitary–adrenal axis under stress: An old concept revisited (2004) (436)
Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans (2013) (416)
Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes (1998) (377)
Intracellular calcium stores regulate activity-dependent neuropeptide release from dendrites (2002) (339)
Oxytocin and vasopressin release within the supraoptic and paraventricular nuclei of pregnant, parturient and lactating rats: A microdialysis study (1993) (335)
V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats (1995) (330)
Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour (1998) (315)
Reduced Anxiety, Conditioned Fear, and Hippocampal Long-Term Potentiation in Transient Receptor Potential Vanilloid Type 1 Receptor-Deficient Mice (2007) (313)
Characterization of the oxytocin system regulating affiliative behavior in female prairie voles (2009) (281)
High vs Low Anxiety-Related Behavior Rats: An Animal Model of Extremes in Trait Anxiety (2002) (275)
Behavioral Consequences of Intracerebral Vasopressin and Oxytocin: Focus on Learning and Memory * * This paper is dedicated to our friend and scientific teacher Prof. Dr Armin Ermisch (1935–1995). (1996) (274)
Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. (1996) (268)
Alterations in Central Neuropeptide Expression, Release, and Receptor Binding in Rats Bred for High Anxiety: Critical Role of Vasopressin (2004) (261)
Identification of Glyoxalase-I as a Protein Marker in a Mouse Model of Extremes in Trait Anxiety (2005) (260)
Anxiolytic and Anti-Stress Effects of Brain Prolactin: Improved Efficacy of Antisense Targeting of the Prolactin Receptor by Molecular Modeling (2001) (257)
Social discrimination procedure: An alternative method to investigate juvenile recognition abilities in rats (1995) (245)
Simultaneous microdialysis in blood and brain: oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat. (1993) (243)
Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects (2009) (242)
Release of Vasopressin within the Rat Paraventricular Nucleus in Response to Emotional Stress: A Novel Mechanism of Regulating Adrenocorticotropic Hormone Secretion? (1996) (241)
Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats (1995) (231)
Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats (1994) (222)
An intrinsic vasopressin system in the olfactory bulb is involved in social recognition (2010) (204)
Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain. (1999) (189)
Blood—Brain Barrier and Peptides (1985) (186)
Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: Focus on vasopressin and glyoxalase-I (2007) (185)
Anxiety: a potential predictor of vulnerability to the initiation of ethanol self-administration in rats (1995) (183)
Long‐Term Antidepressant Treatment Reduces Behavioural Deficits in Transgenic Mice with Impaired Glucocorticoid Receptor Function (1995) (180)
Behavioral, Physiological, and Neuroendocrine Stress Responses and Differential Sensitivity to Diazepam in Two Wistar Rat Lines Selectively Bred for High- and Low-Anxiety–Related Behavior (1998) (176)
Mice selected for high versus low stress reactivity: A new animal model for affective disorders (2008) (172)
Septal vasopressin modulates anxiety-related behaviour in rats (1996) (171)
Vasopressin Mediates the Response of the Combined Dexamethasone/CRH Test in Hyper-anxious Rats: Implications for Pathogenesis of Affective Disorders (2002) (167)
Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain (2000) (165)
Reduction of Hypothalamic Vasopressinergic Hyperdrive Contributes to Clinically Relevant Behavioral and Neuroendocrine Effects of Chronic Paroxetine Treatment in a Psychopathological Rat Model (2003) (163)
The effects of infusion of arginine vasopressin, oxytocin, or their antagonists into the olfactory bulb upon social recognition responses in male rats (1998) (162)
Impaired Repression at a Vasopressin Promoter Polymorphism Underlies Overexpression of Vasopressin in a Rat Model of Trait Anxiety (2004) (158)
Attenuation of Hypothalamic‐Pituitary‐Adrenal Axis Stress Responses in Late Pregnancy: Changes in Feedforward and Feedback Mechanisms (2000) (157)
The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats (2001) (157)
Endogenous oxytocin is involved in short-term olfactory memory in female rats (1998) (154)
Viral vector‐mediated gene transfer of the vole V1a vasopressin receptor in the rat septum: improved social discrimination and active social behaviour (2003) (153)
Systemic Osmotic Stimulation Increases Vasopressin and Oxytocin Release Within the Supraoptic Nucleus (1994) (150)
The vasopressin system--from antidiuresis to psychopathology. (2008) (145)
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies (2011) (145)
Dimensions of emotionality in a rat model of innate anxiety. (2001) (142)
Oxytocin Released within the Supraoptic Nucleus of the Rat Brain by Positive Feedback Action is Involved in Parturition‐Related Events (1996) (140)
Unconditioned anxiety and social behaviour in two rat lines selectively bred for high and low anxiety-related behaviour (2000) (137)
Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats (2004) (135)
Interleukin‐1β Stimulates both Central and Peripheral Release of Vasopressin and Oxytocin in the Rat (1995) (133)
Central and peripheral release of vasopressin and oxytocin in the conscious rat after osmotic stimulation (1988) (133)
Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques (2014) (130)
The involvement of the vasopressin system in stress-related disorders. (2006) (128)
In vivo measurement of a diurnal variation in vasopressin release in the rat suprachiasmatic nucleus (1995) (127)
Neuroendocrine and Behavioral Effects of Repetitive Transcranial Magnetic Stimulation in a Psychopathological Animal Model Are Suggestive of Antidepressant-like Effects (2001) (127)
Long-term ethanol self-administration with repeated ethanol deprivation episodes changes ethanol drinking pattern and increases anxiety-related behaviour during ethanol deprivation in rats (1998) (126)
Proteomics and Metabolomics Analysis of a Trait Anxiety Mouse Model Reveals Divergent Mitochondrial Pathways (2011) (126)
Born to be Anxious: Neuroendocrine and Genetic Correlates of Trait Anxiety in HAB Rats (2003) (126)
An oxytocin receptor antagonist infused into the supraoptic nucleus attenuates intranuclear and peripheral release of oxytocin during suckling in conscious rats. (1994) (125)
Impaired extinction of learned fear in rats selectively bred for high anxiety – evidence of altered neuronal processing in prefrontal-amygdala pathways (2008) (123)
Vasopressin release within the supraoptic and paraventricular nuclei of the rat brain: osmotic stimulation via microdialysis (1991) (122)
A single social defeat experience selectively stimulates the release of oxytocin, but not vasopressin, within the septal brain area of male rats (2000) (120)
Early life stress impairs social recognition due to a blunted response of vasopressin release within the septum of adult male rats (2011) (118)
Genetic predisposition to anxiety-related behavior determines coping style, neuroendocrine responses, and neuronal activation during social defeat. (2006) (117)
Septal and hippocampal release of vasopressin and oxytocin during late pregnancy and parturition in the rat. (1991) (117)
The modified hole board as a differential screen for behavior in rodents (2001) (117)
Maternal Behaviour is Associated with Vasopressin Release in the Medial Preoptic Area and Bed Nucleus of the Stria Terminalis in the Rat (2010) (116)
On the blood-brain barrier to peptides: accumulation of labelled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions. (1985) (110)
The role of endogenous opioids in neurohypophysial and hypothalamo-pituitary-adrenal axis hormone secretory responses to stress in pregnant rats. (1998) (107)
Regulation of activity‐dependent dendritic vasopressin release from rat supraoptic neurones (2005) (107)
Intracerebrally Released Vasopressin and Oxytocin: Measurement, Mechanisms and Behavioural Consequences (1995) (107)
Animal models of anxiety. (2003) (107)
Forced swimming triggers vasopressin release within the amygdala to modulate stress‐coping strategies in rats (2002) (105)
Stable Isotope Metabolic Labeling with a Novel 15N-Enriched Bacteria Diet for Improved Proteomic Analyses of Mouse Models for Psychopathologies (2009) (103)
Behavioural impact of intraseptally released vasopressin and oxytocin in rats (2000) (103)
Differential effects of periodic maternal separation on adult stress coping in a rat model of extremes in trait anxiety (2005) (101)
Alcohol Self-administration in Two Rat Lines Selectively Bred for Extremes in Anxiety-related Behavior (2002) (100)
Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. (1997) (96)
INCREASED BASAL ACTIVITY OF THE HYPOTHALAMO–PITUITARY–ADRENAL AXIS DURING PREGNANCY IN RATS BRED FOR HIGH ANXIETY-RELATED BEHAVIOUR (1998) (96)
Abnormal fluid homeostasis in apelin receptor knockout mice (2009) (95)
Anxiety and Hippocampus Volume in the Rat (2006) (95)
Oxytocin induces preservation of social recognition in male rats by activating α‐adrenoceptors of the olfactory bulb (2000) (95)
Forced swimming stimulates the expression of vasopressin and oxytocin in magnocellular neurons of the rat hypothalamic paraventricular nucleus (2001) (93)
Social isolation after a single defeat reduces striatal dopamine transporter binding in rats (2001) (93)
Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression‐like behaviour: effects of chronic paroxetine treatment (2005) (92)
Neuroendocrine and behavioral response to social confrontation: residents versus intruders, active versus passive coping styles (2005) (89)
Protein Biomarkers in a Mouse Model of Extremes in Trait Anxiety* (2006) (89)
Effects of Morris water maze testing on the neuroendocrine stress response and intrahypothalamic release of vasopressin and oxytocin in the rat (2006) (87)
ABCB1 (MDR1)-Type P-Glycoproteins at the Blood–Brain Barrier Modulate the Activity of the Hypothalamic–Pituitary–Adrenocortical System: Implications for Affective Disorder (2003) (87)
Vasopressin released within the septal brain area during swim stress modulates the behavioural stress response in rats (1999) (87)
Olfactory bulb norepinephrine depletion abolishes vasopressin and oxytocin preservation of social recognition responses in rats (1998) (86)
Septal and Hippocampal Release of Oxytocin, but not Vasopressin, in the Conscious Lactating Rat During Suckling (1989) (84)
Maternal care differs in mice bred for high vs. low trait anxiety: Impact of brain vasopressin and cross-fostering (2011) (82)
Cross-Fostering and Cross-Breeding of HAB and LAB Rats: A Genetic Rat Model of Anxiety (2001) (81)
Urocortin 3 Modulates Social Discrimination Abilities via Corticotropin-Releasing Hormone Receptor Type 2 (2010) (81)
Push‐pull Perfusion and Microdialysis Studies of Central Oxytocin and Vasopressin Release in Freely Moving Rats during Pregnancy, Parturition, and Lactation (1992) (81)
Ageing alters intrahypothalamic release patterns of vasopressin and oxytocin in rats (2000) (79)
Altered Brain Activation Pattern Associated With Drug-Induced Attenuation of Enhanced Depression-Like Behavior in Rats Bred for High Anxiety (2007) (78)
Proteomic and Metabolomic Profiling of a Trait Anxiety Mouse Model Implicate Affected Pathways* (2011) (77)
Altered GABA transmission in a mouse model of increased trait anxiety (2011) (77)
The clinical implications of mouse models of enhanced anxiety. (2011) (76)
Simultaneous Monitoring of Intracerebral Release and Behavior: Endogenous Vasopressin Improves Social Recognition (1994) (76)
Intranasally Administered Neuropeptide S (NPS) Exerts Anxiolytic Effects Following Internalization Into NPS Receptor-Expressing Neurons (2012) (75)
Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. (2000) (75)
Differential Stress-Induced Neuronal Activation Patterns in Mouse Lines Selectively Bred for High, Normal or Low Anxiety (2009) (74)
Vasopressin facilitates its own release within the rat supraoptic nucleus in vivo. (1994) (74)
Release of vasopressin within the brain contributes to neuroendocrine and behavioral regulation. (1998) (73)
Rhythmicity in Mice Selected for Extremes in Stress Reactivity: Behavioural, Endocrine and Sleep Changes Resembling Endophenotypes of Major Depression (2009) (73)
A Hypomorphic Vasopressin Allele Prevents Anxiety-Related Behavior (2009) (73)
Release of vasopressin and oxytocin by paraventricular stimulation in rats. (1990) (70)
Stress- and corticosteroid-induced modulation of the locomotor response to morphine in rats (1999) (69)
High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats (2004) (65)
Cognitive performance in rats differing in their inborn anxiety. (2002) (64)
Simultaneous measurement of arginine vasopressin and oxytocin in plasma and neurohypophyses by radioimmunoassay. (1981) (64)
Dendritic Morphology of Hippocampal and Amygdalar Neurons in Adolescent Mice Is Resilient to Genetic Differences in Stress Reactivity (2012) (64)
Microdialysis administration of vasopressin and vasopressin antagonists into the septum during pole-jumping behavior in rats. (1992) (64)
Behavioral and Neurobiological Effects of Deep Brain Stimulation in a Mouse Model of High Anxiety- and Depression-Like Behavior (2013) (63)
Plasma vasopressin and oxytocin in response to exercise and during a day-night cycle in man. (1982) (63)
Reliability of high and low anxiety-related behaviour: influence of laboratory environment and multifactorial analysis (2002) (63)
Vasopressin from hypothalamic magnocellular neurons has opposite actions at the adenohypophysis and in the supraoptic nucleus on ACTH secretion (2002) (62)
Selective Activation of the Hypothalamic Vasopressinergic System in Mice Deficient for the Corticotropin-Releasing Hormone Receptor 1 Is Dependent on Glucocorticoids* * This work was supported by the Volkswagen Stiftung (to F.H. and W.W.). (2000) (62)
Oxytocin and vasopressin release in discrete brain areas after naloxone in morphine-tolerant and -dependent anesthetized rats: push-pull perfusion study (1992) (61)
Reduced febrile responses to pyrogens after lesions of the hypothalamic paraventricular nucleus. (1994) (60)
Methylglyoxal‐mediated anxiolysis involves increased protein modification and elevated expression of glyoxalase 1 in the brain (2010) (59)
Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging. (1996) (59)
Anxiety- rather than depression-like behavior is associated with adult neurogenesis in a female mouse model of higher trait anxiety- and comorbid depression-like behavior (2012) (58)
Melanocortin Receptor Agonists Facilitate Oxytocin-Dependent Partner Preference Formation in the Prairie Vole (2015) (55)
Increased stress reactivity is associated with cognitive deficits and decreased hippocampal brain-derived neurotrophic factor in a mouse model of affective disorders. (2010) (55)
Listening to neuropeptides by microdialysis: Echoes and new sounds? (2008) (54)
Vasopressin binds to microvessels from rat hippocampus (1986) (53)
Vasopressin administration via microdialysis into the septum interferes with the acquisition of spatial memory in rats (1992) (52)
Osmotic responsiveness and cross talk involving oxytocin, but not vasopressin or amino acids, between the supraoptic nuclei in virgin and lactating rats (1995) (52)
Vasopressin, major depression, and hypothalamic–pituitary–adrenocortical desensitization (2000) (52)
Plasma oxytocin concentrations in man after different routes of administration of synthetic oxytocin. (2009) (51)
Endocrine and behavioral effects of airpuff-startle in rats (1996) (51)
Central and peripheral administration of atriopeptin is anxiolytic in rats. (1997) (51)
The CRH1 receptor antagonist R121919 attenuates stress-elicited sleep disturbances in rats, particularly in those with high innate anxiety. (2002) (51)
Stimulation of oxytocin release within the supraoptic nucleus and into blood by CCK-8. (1994) (50)
Does the release of vasopressin within the supraoptic nucleus of the rat brain depend upon changes in osmolality and Ca2+/K+? (1992) (49)
Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids. (2000) (49)
Endogenous vasopressin contributes to hypothalamic-pituitary-adrenocortical alterations in aged rats. (2000) (49)
Vasopressin and oxytocin in rat brain in response to prostaglandin fever. (1990) (48)
On the Blood‐Brain Barrier to Peptides: [3H]βCasomorphin‐5 Uptake by Eighteen Brain Regions In Vivo (1983) (48)
Bidirectional rescue of extreme genetic predispositions to anxiety: impact of CRH receptor 1 as epigenetic plasticity gene in the amygdala (2014) (48)
Selective Breeding for High Anxiety Introduces a Synonymous SNP That Increases Neuropeptide S Receptor Activity (2015) (48)
Different Patterns of Respiration in Rat Lines Selectively Bred for High or Low Anxiety (2013) (48)
Profiling Trait Anxiety: Transcriptome Analysis Reveals Cathepsin B (Ctsb) as a Novel Candidate Gene for Emotionality in Mice (2011) (47)
Chapter 6: Central release of vasopressin: stimuli, dynamics, consequences (1992) (47)
Regional net uptake of 14C-glucose by rat brain under the influence of corticosterone. (1978) (46)
Rapid effect on suckling of an oxytocin antisense oligonucleotide administered into rat supraoptic nucleus. (1994) (44)
Neuropeptides in anxiety modulation. (2005) (44)
Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides. (1997) (43)
Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results (2002) (43)
Plasma levels of oxytocin and vasopressin before, during and after parturition in cows. (2009) (42)
Release of vasopressin and oxytocin within the brain and into blood: microdialysis and antisense targeting (1995) (42)
Indications for a brain uptake of labelled vasopressin and ocytocin and the problem of the blood-brain barrier. (1979) (42)
Human intestinal trefoil factor is expressed in human hypothalamus and pituitary: evidence for a novel neuropeptide (1996) (41)
The positive feedback action of vasopressin on its own release from rat septal tissue in vitro is receptor-mediated (1991) (40)
Airjet and FG-7142-induced Fos expression differs in rats selectively bred for high and low anxiety-related behavior (2006) (40)
Direct hypertonic stimulation of the rat supraoptic nucleus increases c-fos expressionin glial cells rather than magnocellular neurones (1996) (40)
Increased stress reactivity is associated with reduced hippocampal activity and neuronal integrity along with changes in energy metabolism (2012) (40)
The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats. (2003) (40)
Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats (1994) (39)
Sleep disturbances in highly stress reactive mice: Modeling endophenotypes of major depression (2011) (39)
Diabetes insipidus and, partially, low anxiety‐related behaviour are linked to a SNP‐associated vasopressin deficit in LAB mice (2007) (39)
Proteomic-based genotyping in a mouse model of trait anxiety exposes disease-relevant pathways (2010) (39)
Swim stress triggers the release of vasopressin within the suprachiasmatic nucleus of male rats (1998) (39)
Co-segregation of hyperactivity, active coping styles, and cognitive dysfunction in mice selectively bred for low levels of anxiety (2013) (39)
Measurement of septal release of vasopressin and oxytocin by the push-pull technique following electrical stimulation of the paraventricular nucleus of rats (1988) (39)
Enhanced morphine-induced behavioural effects and dopamine release in the nucleus accumbens in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: influence of long-term treatment with the antidepressant moclobemide (1998) (38)
Enhanced Fear Expression in a Psychopathological Mouse Model of Trait Anxiety: Pharmacological Interventions (2011) (38)
Modeling psychotic and cognitive symptoms of affective disorders: Disrupted latent inhibition and reversal learning deficits in highly stress reactive mice (2010) (38)
Osmotic stimulation of the supraoptic nucleus: central and peripheral vasopressin release and blood pressure. (1994) (38)
Central Administration of IL-1 Reduces Anxiety and Induces Sickness Behaviour in Rats (1997) (38)
Two Wistar Rat Lines Selectively Bred for Anxiety-Related Behavior Show Opposite Reactions in Elevated Plus Maze and Fear-Sensitized Acoustic Startle Tests (2004) (37)
Differential ventral septal vasopressin release is associated with sexual dimorphism in PGE2 fever. (1997) (35)
Arginine vasopressin and adrenocorticotropin secretion in response to psychosocial stress is attenuated by ethanol in sons of alcohol-dependent fathers. (2004) (34)
Polymorphism in Tmem132d regulates expression and anxiety-related behavior through binding of RNA polymerase II complex (2018) (34)
Vasopressin administration into the paraventricular nucleus normalizes plasma oxytocin and corticosterone levels in Brattleboro rats. (2009) (34)
Vasopressin and oxytocin in CSF and plasma of patients with aneurysmal subarachnoid haemorrhage (2014) (34)
Release of vasopressin from supraoptic neurons within the median eminence in vivo. A combined microdialysis and push-pull perfusion study in the rat (1996) (34)
Behavioral extremes of trait anxiety in mice are characterized by distinct metabolic profiles. (2014) (33)
A mouse model of high trait anxiety shows reduced heart rate variability that can be reversed by anxiolytic drug treatment (2011) (32)
Neuropeptides and anxiety-related behavior. (2001) (32)
Stimulus‐Specific Neuroendocrine Responses to Osmotic Challenges in Apelin Receptor Knockout Mice (2010) (31)
Hypothalamic and Hippocampal Release of Serotonin in Rats Bred for Hyper- or Hypo-anxiety (2002) (31)
Vasopressin Antisense Oligonucleotide Induces Temporary Diabetes Insipidus in Rats (1994) (31)
Increased levels of conditioned fear and avoidance behavior coincide with changes in phosphorylation of the protein kinase B (AKT) within the amygdala in a mouse model of extremes in trait anxiety (2012) (31)
Taurine selectively modulates the secretory activity of vasopressin neurons in conscious rats (2001) (30)
GABA selectively controls the secretory activity of oxytocin neurons in the rat supraoptic nucleus (2004) (29)
Oxytocin neurone autoexcitation during morphine withdrawal in anaesthetized rats (1997) (29)
Neural input modulates osmotically stimulated release of vasopressin into the supraoptic nucleus. (1996) (29)
Genetic predisposition to anxiety-related behavior predicts predator odor response (2011) (28)
Naloxone increases the release of oxytocin, but not vasopressin, within limbic brain areas of conscious parturient rats: a push-pull perfusion study. (1991) (28)
Altered hypothalamo–pituitary–adrenal and sympatho-adrenomedullary activities in rats bred for high anxiety: central and peripheral correlates (2006) (27)
Antisense targeting in behavioural neuroendocrinology. (1996) (26)
Decreased sensitivity to thermal pain in rats bred for high anxiety-related behaviour is attenuated by citalopram or diazepam treatment (2007) (25)
Microdialysis with High NaCl Causes Central Release of Amino Acids and Dopamine (1995) (24)
Low vagally-mediated heart rate variability and increased susceptibility to ventricular arrhythmias in rats bred for high anxiety (2014) (24)
Central release of vasopressin: stimuli, dynamics, consequences. (1992) (24)
Immune challenge induces differential corticosterone and interleukin-6 responsiveness in rats bred for extremes in anxiety-related behavior (2008) (24)
Release of oxytocin within the supraoptic nucleus. Mechanisms, physiological significance and antisense targeting. (1995) (24)
Peptide receptors of the cerebral capillary endothelium and the transport of amino acids across the blood-brain barrier (1988) (23)
Identification of a Role for the Ventral Hippocampus in Neuropeptide S-Elicited Anxiolysis (2013) (23)
Behavioral consequences of intracerebral vasopressin and oxytocin (1996) (22)
Enhanced fear expression in a psychphathological mouse model of trait anxiety: pharmacological interventions (2010) (22)
Sleep Phenotyping in a Mouse Model of Extreme Trait Anxiety (2012) (22)
Some observations indicating a low brain uptake of [3H]Nle11-Substance P. (1983) (22)
Intranasally Applied Neuropeptide S Shifts a High-Anxiety Electrophysiological Endophenotype in the Ventral Hippocampus towards a "Normal"-Anxiety One (2015) (22)
Confinement to the open arm of the elevated-plus maze as anxiety paradigm: behavioral validation. (2006) (21)
Verapamil prevents withdrawal excitation of oxytocin neurones in morphine-dependent rats (2000) (21)
Neuroendocrine and behavioral effects of antisense oligonucleotides. (1997) (21)
Steroid Synthesis Inhibition with Ketoconazole and its Effect upon the Regulation of the Hypothalamus–Pituitary–Adrenal System in Healthy Humans* (2003) (20)
The influence of vasopressin on the regional uptake of [3H] orotic acid by rat brain. (1978) (20)
Intrahippocampal Corticosterone Response in Mice Selectively Bred for Extremes in Stress Reactivity: A Microdialysis Study (2010) (20)
A polymorphism in the Crhr1 gene determines stress vulnerability in male mice. (2014) (19)
Real-Time Imaging of Amygdalar Network Dynamics In Vitro Reveals a Neurophysiological Link to Behavior in a Mouse Model of Extremes in Trait Anxiety (2013) (19)
Vasopressin and oxytocin in cerebrospinal fluid and plasma of conscious rabbits--response to dehydration and haemorrhage. (1983) (18)
Advances in vasopressin and oxytocin--from genes to behaviour to disease. Preface. (2008) (18)
Vasopressin signaling at brain level controls stress hormone release: the vasopressin-deficient Brattleboro rat as a model (2015) (18)
Suppression of PGE2 fever at near term: reduced thermogenesis but not enhanced vasopressin antipyresis. (1999) (17)
Temazepam Triggers the Release of Vasopressin into the Rat Hypothalamic Paraventricular Nucleus: Novel Insight into Benzodiazepine Action on Hypothalamic–Pituitary–Adrenocortical System Activity During Stress (2006) (17)
Downregulation of brain mineralocorticoid and glucocorticoid receptor by antisense oligodeoxynucleotide treatment fails to alter spatial navigation in rats. (1998) (16)
Gene expression profiling in the stress control brain region hypothalamic paraventricular nucleus reveals a novel gene network including Amyloid beta Precursor Protein (2010) (16)
The endocrine stress response is linked to one specific locus on chromosome 3 in a mouse model based on extremes in trait anxiety (2012) (15)
HAB/LAB rats: an animal model of extremes in trait anxiety and depression (2003) (15)
The 15N isotope effect as a means for correlating phenotypic alterations and affected pathways in a trait anxiety mouse model (2012) (14)
Tracking oxytocin functions in the rodent brain during the last 30 years: From push‐pull perfusion to chemogenetic silencing (2019) (14)
Vasopressin receptors in the brain, liver and kidney of rats following osmotic stimulation (1991) (14)
The glycolytic metabolite methylglyoxal induces changes in vigilance by generating low-amplitude non-REM sleep (2013) (14)
Pharmacological Characterisation of Cortical γ-Aminobutyric Acid Type A (GABAA) Receptors in Two Wistar Rat Lines Selectively Bred for High and Low Anxiety-Related Behaviour (2000) (13)
Endogenous opioids regulate intracerebral oxytocin release during parturition in a region-specific manner. (1992) (12)
Levels of vasopressin and oxytocin in neurohypophysis and plasma of the postnatally developing rat and the influence of hypothyroidism on rat fetuses. (2009) (12)
Vasopressin and oxytocin in brain areas of rats selectively bred for differences in behavioral performance (1992) (12)
¹⁵N metabolic labeling: evidence for a stable isotope effect on plasma protein levels and peptide chromatographic retention times. (2013) (12)
Vasopressin in cerebrospinal fluid (CSF) and plasma of conscious rabbits--circadian variations. (2009) (11)
Suppression of PGE(2) fever at near term: reduced thermogenesis but not enhanced vasopressin antipyresis. (1999) (11)
Nitric oxide is not involved in the control of vasopressin release during acute forced swimming in rats (2004) (11)
Epigenetic Mechanisms Within the Cingulate Cortex Regulate Innate Anxiety-Like Behavior (2019) (11)
[Effect of oxytocin on regional 3H-orotic acid uptake in rat brain]. (1977) (11)
Enhanced conditioning of adverse memories in the mouse modified swim test is associated with neuroinflammatory changes – Effects that are susceptible to antidepressants (2020) (11)
Release of vasopressin within the rat suprachiasmatic nucleus: no effect of a V1/V2 antagonist. (1996) (11)
Neuroendocrine stress mechanisms regulating ACTH and oxytocin in pregnancy. (1999) (10)
Glycogen synthase kinase-3β inhibition in the medial prefrontal cortex mediates paradoxical amphetamine action in a mouse model of ADHD (2015) (10)
Circumventricular organs and brain fluid environment: molecular and functional aspects. Proceedings of the 4th Reinhardsbrunn Symposium. Leipzig, Germany, March 24-29, 1991. (1992) (9)
Differential central and peripheral release of vasopressin and oxytocin in response to swim stress in rats. (1998) (9)
Effects of osmotic stimulation of the supraoptic nucleus on central and peripheral release of vasopressin and on baro- and thermoregulation (1994) (9)
Neural nitric oxide gene inactivation affects the release profile of oxytocin into the blood in response to forced swimming. (2007) (9)
Enriched environment impacts trimethylthiazoline‐induced anxiety‐related behavior and immediate early gene expression: critical role of Crhr1 (2014) (9)
Direct osmotic stimulation of the hypothalamic paraventricular nucleus by microdialysis induces excessive grooming in the rat (1994) (9)
Oxytocin in Brattleboro Rats: Increased Synthesis is Contrasted by Blunted Intrahypothalamic Release From Supraoptic Nucleus Neurones (2013) (8)
Opioids influence neurohypophysial but not central oxytocin release following direct hyperosmotic stimulation of the supraoptic nucleus in urethane-anaesthetised rats (1994) (7)
Vasopressin, the blood-brain barrier, and brain performance. (1990) (7)
Crosstalk in the magnocellular system during osmotic stimulation of one supraoptic nucleus (1994) (7)
The involvement of neuropeptides in evolution, signaling, behavioral regulation and psychopathology: focus on vasopressin (2005) (7)
Taurine regulates corticotropin secretion at the level of the supraoptic nucleus during stress in rats (2003) (6)
Oxytocin, Norepinephrine and Olfactory Bulb Mediated Recognition (2001) (6)
Connecting Anxiety and Genomic Copy Number Variation: A Genome-Wide Analysis in CD-1 Mice (2015) (6)
Radioimmunoassay measurement of plasma oxytocin and vasopressin in cows during machine milking. (1982) (6)
Hyperosmotic Stimulation of the Hypothalamic Paraventricular and Supraoptic Nuclei Alters Body Temperature in the Normothermic and Febrile Rat (1994) (5)
Transfer of [3H]leucine across the blood-brain barrier at high blood-side oxytocin concentrations in normal and morphine-dependent rats (1992) (5)
Environmental manipulations generate bidirectional shifts in both behavior and gene regulation in a crossbred mouse model of extremes in trait anxiety (2014) (5)
The effect of treatment with ketoconazole on central CRH systems of depressed patients (2011) (5)
Intracerebral Release of Vasopressin and Oxytocin: New Aspects of the Old Concept of Neurosecretion (1997) (4)
Inborn vs. Acquired Anxiety in Cross-Breeding and Cross-Fostering HAB/LAB Mice Bred for Extremes in Anxiety-Related Behavior (2019) (4)
Neuropetide Y, calcitonin gene-related peptide and CRH in brain of rats bred for high anxiety-related behaviors (2007) (4)
Osmotic stimulation of the supraoptic nucleus (1994) (4)
The anxiolytic effect of the novel CRH1 receptor antagonist R121919 depends on innate emotionality in rats (2000) (4)
Chronic treatment with a selective neurokinin-1 receptor antagonist in a mouse model of trait anxiety and depression: focus on behaviour and neuropeptidergic mechanisms (2008) (4)
[Cystine aminopeptidase and oxytocin in the plasma of pregnant patients with premature labor]. (1985) (3)
Reduced febrile responses to central and peripheral pyrogens following electrolytic lesions of the hypothalamic paraventricular nucleus (1994) (3)
84 – Genetic Transmission of Behavior and Its Neuroendocrine Correlates (2009) (3)
Expression of the trefoil polypeptide ITF in PC12 cells (1997) (3)
Involvement of Vasopressin in Hypothalamic-Pituitary-Adrenal (HPA) System Alterations (1997) (3)
Mice selected for high or low stress reactivity: A new animal model for affective disorders (2006) (3)
Vasopressin selectively modulates the release of taurine within the septum of the rat brain (1999) (3)
Vasopressin administration into the PVN normalizes plasma oxytocin and corticosterone levels in Brattleboro rats (2009) (2)
Neuropeptides and Anxiety (2001) (2)
Inbred low anxiety-related behavior (LAB) mice - a mouse model of attention-deficit hyperactivity disorder (ADHD)? (2011) (2)
Biomarker discovery by stable isotope labeling and quantitative proteomics (2010) (2)
231. Antisense “knockdown” of CRH1- but not of CRH2-Receptors is anxiolytic in rats (1996) (2)
The endocrine stress response is linked to one specific locus on chromosome 3 in a mouse model based on extremes in trait anxiety (2012) (2)
S.24.03 Rodent models of impaired fear extinction: therapeutic approaches (2011) (1)
PW01-45 - Biomarker Discovery For Psychiatric Disorders By Stable Isotope Metabolic Labeling and Quantitative Proteomics (2010) (1)
CCK-8 stimulates oxytocin release within the supraoptic nucleus and into blood - a microdialysis study (1993) (1)
The role of substance P in fear and anxiety (2009) (1)
Functional characterization of single-nucleotide polymorphisms in the HAB/LAB mouse Tmem132d promoter (2011) (1)
Osmotic stimulation of the supraoptic nucleus: comparison of central and peripheral vasopressin release and effects on blood pressure (1994) (1)
15N metabolic labeling of high and low anxiety-related behavior HAB/LAB mice (2007) (1)
Behavioral Performance of Rats and the Content of Vasopressin and Oxytocin in Distinct Brain Areas (1986) (1)
Glyoxalase I: Implications for an enzyme involved in trait anxiety (2005) (1)
Proteomic genotyping in a mouse model of trait anxiety exposes disease relevant pathways (2009) (1)
Low vagally-mediated heart rate variability and increased susceptibility to ventricular arrhythmias in rats bred for high increased susceptibility anxiety (2014) (1)
A neutron can make the difference: The 15N stable isotope effect on metabolic pathways (2013) (1)
Effects of enriched environment on a mouse model of extremes in trait anxiety (2009) (1)
High-anxiety and low-anxiety rats display differences in CNS Fos expression in response to open field exposure (2002) (1)
Transcranial magnetic stimulation induces changes in coping strategies and attenuates the activity of the hypothalamic-pituitary-adrenocortical system in rats (1998) (0)
Neurotransmitter und Modulatoren (2008) (0)
Adult neurogenesis in a psychopathological mouse model of trait anxiety and comorbid depression-like behavior: effect of antidepressants (2009) (0)
Neurobiological correlates of pathological anxiety studied in psychopathological rodent models (2006) (0)
Stress-induced gene expression in the paraventricular nucleus of hypothalamus in the mouse strains DBA/2J and C57BL/6J – potential signalling pathways involved (2009) (0)
Involvement of intra-coerulear galanin in the pathophysiology and pharmacotherapy of depression (2015) (0)
HAB/LAB Mice and Rats: Approaching the Genetics and Epigenetics of Trait Anxiety (2018) (0)
S.12.01 Identification of a significant role for the ventral hippocampus in neuropeptide S-elicited anxiolysis (2013) (0)
S.11.04 The use of inbred strains for the development of animal models of anxiety (2008) (0)
Neurobiological correlates of successful deep brain stimulation in a mouse model of high trait affect (2012) (0)
The role of tachykinin 1 in a mouse model of trait anxiety (2007) (0)
Behavioural and neuroendocrine effects of antisense targeting in the rat. (1999) (0)
Mice selected for high or low stress reactivity: a proposed model for affective disorders (2005) (0)
Electrophysiological correlates of trait anxiety in mice (2009) (0)
The galanin system in depression and antidepressant treatment: focus on the locus coeruleus (2012) (0)
S.22.05 Candidate genes of anxiety and depression: from mice and rats to men (2005) (0)
Ventral septal AVP release in the febrile hypertensive and normotensive rat (1994) (0)
Differential galanin and enkephalin gene expression in two rat lines selectively bred for high and low anxiety-related behaviour (2004) (0)
EFFFECTS OF INTRA-ACCUMBENS INJECTIONS OF DAMGO, DPDPE AND NALOXONE ON ETHANOL SELF-ADMINISTRATION (1996) (0)
Vasopressin signaling at brain level controls stress hormone release: the vasopressin-deficient Brattleboro rat as a model (2015) (0)
Pharmacology of neuropeptide S in a mouse model of extremes in anxiety-related behavior (2009) (0)
Contents, Vol. 54, 1991 (1991) (0)
Mice selected for extremes in stress reactivity: modeling clinically relevant endophenotypes of major depression (2009) (0)
Vasopressin antisense oligonucleotide induces temporary diabetes insipidus in rats. (1994) (0)
Sleep/wake behavior in the stress reactivity mouse model - a new animal model to investigate sleep impairments in major depression (2008) (0)
Adult neurogenesis in a mouse model of affective behavior: pharmacological and non-pharmacological interventions (2011) (0)
Linking cognitive abilities and stress reactivity: insights from the HR/IR/LR mouse model (2007) (0)
ATP: A neurotransmitter regulating hypothalamic-pituitary-adrenal axis function? (2000) (0)
[Neurobiology and genetics of anxiety in an animal model]. (2003) (0)
Genetic predisposition to extremes in anxiety-related behavior (2008) (0)
Expressing emotions: Avp and Crh are involved in the phenotype of mice bred for extremes in anxiety-related behavior (2007) (0)
The κ-opioid receptor antagonist nor-binaltorphimine (nor-BNI) facilitates the development of morphine-induced behavioral sensitization (1995) (0)
Neuroendocrine regulation in mice deficient for the corticotropin-releasing hormone receptor 1 (CRHR1): activation of the vasopressinergic system and involvement of CRHR1 in adrenocortical function (2000) (0)
Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders (2004) (0)
Subject Index Vol. 54, 1991 (1991) (0)
Do plasma oxytocin and vasopressin indicate effects of bonding therapy and interpersonal trust (2013) (0)
Title Polymorphism in Tmem 132 d regulates expression and anxiety-related behavior through binding of RNA polymerase II complex (2018) (0)
A key role for hypothalamic AVP in anxiety/depression-related behavior and social recognition: An antisense study (2005) (0)
Altered corticolimbic processing in rodent models of enhanced anxiety and depression (2008) (0)
Phenotypic and genetic characterization of a short-term selective breeding for anxiety-related behavior (2011) (0)
Stable isotope metabolic labeling of a mouse model reveals synaptic biomarkers for anxiety disorders (2009) (0)
Behavioural, neuroendocrine and neuronal responses of lactating residents to maternal defense is dependent on their inborn level of anxiety. (2002) (0)
Guest Editorial (2003) (0)
Stimulation of oxytocin release within the hypothalamic magnocellular nuclei and into blood by peripheral and central CCK-8 (1994) (0)
Temporal aspects of HPA axis reactivity and regulation: microdialysis studies in the HR/IR/LR mouse model (2009) (0)
Involvement of intra-coerulear galanin in enhanced depression-related behaviour and antidepressant pharmacotherapy (2011) (0)
Anxiety and mitochondria: Insights from the -omics world (2011) (0)
Genetic polymorphisms involved in the regulation of anxiety and depression-like behaviour in rodents (2005) (0)
P.1.011 Identification of a significant role for the ventral hippocampus in neuropeptide S-elicited anxiolysis (2013) (0)
Metabolic Activation of the Magnocellular System during Lactation by Microdialysis of Hypertonic CSF into One Supraoptic Nucleus a (1993) (0)
Molecular-genetic dissection of anxiety/depression: From HAB phenotype to functional SNP (2004) (0)
Lack of fever suppression or central AVP release in 1K1C hypertensive rats (1994) (0)
Neuroendocrinology (2004) (0)
Mitochondria as pharmacological targets for anxiolytic treatment (2015) (0)
Brain biochemistry markers differentiate between animal models of anxiety and depression (2007) (0)
Inbred low anxiety-related behavior mice: a mouse model of attention-deficit hyperactivity disorder (2011) (0)
Polymorphisms underlying innate anxiety (2002) (0)
P.4.b.002 Brain biochemistry markers differentiate between animal models of anxiety and depression (2007) (0)
Neuropeptides in animal models of anxiety (2000) (0)
Tmem132d: a novel biomarker for anxiety disorders (2009) (0)
Central glucocorticoid system dysfunction in a mouse model of extreme anxiety: clinical implications (2013) (0)
Validation of a genetic mouse model for anxiety and comorbid depression (2004) (0)
S.20.02 Anxiety, depression and adult neurogenesis (2014) (0)
The galanin system in depression and antidepressant treatment: focus on the locus coeruleus (2012) (0)
Short-term effects of vasopressin and oxytocin antisense oligonucleotides on the activity of rat neurohypophysial neurons in vivo (1995) (0)
Copy number variants in two mouse models of affective disorders (2011) (0)
The brain vasopressin system is a final common pathway in trait anxiety and depression-like behavior (2006) (0)
245. Repetitive transcranial magnetic stimulation—evidence for antidepressant-like and neuroprotective effects (2000) (0)
High trait anxiety in a genetic rat model: association with altered diazepam response and gene expression in the medial prefrontal/anterior cingulate cortex (2003) (0)
The voice of silent mutations: Regulatory SNPs in Npsr1 have implications for panic disorder patients (2013) (0)
OXYTOCIN INFLUENCES ON THE CNS OF HEALTHY YOUNG MEN (1981) (0)
[Serotonin in brain regions of rats differing in their inborn locomotor activity]. (2002) (0)
Pharmacologic fMRI (phMRI) at 7 Tesla reveals candidate regions for pathological regulation of emotional behavior in an animal model of high innate anxiety (2002) (0)
P.4.c.003 Identification of a significant role for the ventral hippocampus in neuropeptide S-elicited anxiolysis (2013) (0)
Basal cerebral activity in a mouse model of trait anxiety as revealed by in vivo manganese enhanced MRI and cytochrome-c oxidase staining (2011) (0)
The effects of chronic immune stimulation on central and peripheral levels of oxytocin and vasopressin (2010) (0)
O-25-3 The combined dexamethasone/CRH-test in rats: Characterization of the HPA axis activity in aging (1996) (0)
Recognising Significant Others by Smell; the Role of Vasopressin in the Olfactory System. (2011) (0)
S.24.02 High and low anxiety rat and mouse models: behaviour and neuropeptides (2007) (0)
Major role for vasopressin in a new mouse model of anxiety and depression (2005) (0)
Vasopressin release within the rat brain and its behavioural significance (1993) (0)
Differences in intrinsic amygdalar network features between animals of the high- vs. low-anxiety-related behavior (HAB, LAB) mouse model (2011) (0)
S.3.01 Biomarkers for anxiety disorders: proteomic and systems biology approaches (2011) (0)
Limbic NF-KB signalling controls stress-induced anxiety and antidepressant effects independently of the HPA axis (2010) (0)
Neurobiological correlates of successful deep brain stimulation in a mouse model of high trait affect (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Rainer Landgraf?

Rainer Landgraf is affiliated with the following schools:

Rainer Landgraf's Academic­Influence.com Rankings

Rainer Landgraf's Degrees

Why Is Rainer Landgraf Influential?

Rainer Landgraf's Published Works

Published Works

What Schools Are Affiliated With Rainer Landgraf?

Rainer Landgraf's AcademicInfluence.com Rankings